nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0718	0.126	CbGbCtD
Dantrolene—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0675	0.119	CbGbCtD
Dantrolene—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0675	0.119	CbGbCtD
Dantrolene—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0611	0.107	CbGbCtD
Dantrolene—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0611	0.107	CbGbCtD
Dantrolene—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0527	0.0925	CbGbCtD
Dantrolene—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0512	0.0898	CbGbCtD
Dantrolene—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0463	0.0812	CbGbCtD
Dantrolene—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0463	0.0812	CbGbCtD
Dantrolene—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0444	0.0779	CbGbCtD
Dantrolene—RYR3—lymphoid tissue—acquired immunodeficiency syndrome	0.00827	0.0896	CbGeAlD
Dantrolene—RYR3—digestive system—acquired immunodeficiency syndrome	0.00817	0.0885	CbGeAlD
Dantrolene—RYR3—blood—acquired immunodeficiency syndrome	0.00778	0.0843	CbGeAlD
Dantrolene—RYR3—spinal cord—acquired immunodeficiency syndrome	0.0075	0.0812	CbGeAlD
Dantrolene—RYR3—vagina—acquired immunodeficiency syndrome	0.00722	0.0782	CbGeAlD
Dantrolene—RYR3—lung—acquired immunodeficiency syndrome	0.00682	0.0739	CbGeAlD
Dantrolene—RYR3—nervous system—acquired immunodeficiency syndrome	0.00632	0.0685	CbGeAlD
Dantrolene—RYR3—central nervous system—acquired immunodeficiency syndrome	0.00608	0.0659	CbGeAlD
Dantrolene—RYR1—blood—acquired immunodeficiency syndrome	0.00558	0.0605	CbGeAlD
Dantrolene—RYR1—vagina—acquired immunodeficiency syndrome	0.00518	0.0561	CbGeAlD
Dantrolene—RYR3—brain—acquired immunodeficiency syndrome	0.00483	0.0523	CbGeAlD
Dantrolene—RYR1—nervous system—acquired immunodeficiency syndrome	0.00453	0.0491	CbGeAlD
Dantrolene—RYR1—central nervous system—acquired immunodeficiency syndrome	0.00436	0.0473	CbGeAlD
Dantrolene—RYR1—brain—acquired immunodeficiency syndrome	0.00347	0.0375	CbGeAlD
Dantrolene—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00265	0.0287	CbGeAlD
Dantrolene—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00102	0.011	CbGeAlD
Dantrolene—CYP3A4—blood—acquired immunodeficiency syndrome	0.000971	0.0105	CbGeAlD
Dantrolene—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000788	0.00854	CbGeAlD
Dantrolene—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000759	0.00822	CbGeAlD
Dantrolene—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000432	0.00128	CcSEcCtD
Dantrolene—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000431	0.00128	CcSEcCtD
Dantrolene—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.00127	CcSEcCtD
Dantrolene—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00043	0.00127	CcSEcCtD
Dantrolene—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00043	0.00127	CcSEcCtD
Dantrolene—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00043	0.00127	CcSEcCtD
Dantrolene—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00043	0.00127	CcSEcCtD
Dantrolene—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000429	0.00127	CcSEcCtD
Dantrolene—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000429	0.00127	CcSEcCtD
Dantrolene—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000429	0.00127	CcSEcCtD
Dantrolene—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000428	0.00127	CcSEcCtD
Dantrolene—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000427	0.00126	CcSEcCtD
Dantrolene—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000426	0.00126	CcSEcCtD
Dantrolene—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000426	0.00126	CcSEcCtD
Dantrolene—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000426	0.00126	CcSEcCtD
Dantrolene—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000425	0.00126	CcSEcCtD
Dantrolene—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000425	0.00126	CcSEcCtD
Dantrolene—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000425	0.00126	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000425	0.00126	CcSEcCtD
Dantrolene—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000424	0.00126	CcSEcCtD
Dantrolene—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000423	0.00125	CcSEcCtD
Dantrolene—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000423	0.00125	CcSEcCtD
Dantrolene—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000422	0.00125	CcSEcCtD
Dantrolene—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.00124	CcSEcCtD
Dantrolene—Rash—Didanosine—acquired immunodeficiency syndrome	0.000419	0.00124	CcSEcCtD
Dantrolene—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000419	0.00124	CcSEcCtD
Dantrolene—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000419	0.00124	CcSEcCtD
Dantrolene—Headache—Didanosine—acquired immunodeficiency syndrome	0.000416	0.00123	CcSEcCtD
Dantrolene—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000415	0.00123	CcSEcCtD
Dantrolene—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000415	0.00123	CcSEcCtD
Dantrolene—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000415	0.00123	CcSEcCtD
Dantrolene—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000414	0.00122	CcSEcCtD
Dantrolene—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000414	0.00122	CcSEcCtD
Dantrolene—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000413	0.00122	CcSEcCtD
Dantrolene—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000413	0.00122	CcSEcCtD
Dantrolene—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000412	0.00122	CcSEcCtD
Dantrolene—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000412	0.00122	CcSEcCtD
Dantrolene—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000412	0.00122	CcSEcCtD
Dantrolene—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000411	0.00121	CcSEcCtD
Dantrolene—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00041	0.00121	CcSEcCtD
Dantrolene—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000409	0.00121	CcSEcCtD
Dantrolene—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000409	0.00121	CcSEcCtD
Dantrolene—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000408	0.00121	CcSEcCtD
Dantrolene—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000408	0.00121	CcSEcCtD
Dantrolene—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000408	0.00121	CcSEcCtD
Dantrolene—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000407	0.0012	CcSEcCtD
Dantrolene—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000407	0.0012	CcSEcCtD
Dantrolene—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000405	0.0012	CcSEcCtD
Dantrolene—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000405	0.0012	CcSEcCtD
Dantrolene—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000402	0.00119	CcSEcCtD
Dantrolene—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000402	0.00119	CcSEcCtD
Dantrolene—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000402	0.00119	CcSEcCtD
Dantrolene—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000402	0.00119	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000401	0.00119	CcSEcCtD
Dantrolene—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000399	0.00118	CcSEcCtD
Dantrolene—Pain—Indinavir—acquired immunodeficiency syndrome	0.000399	0.00118	CcSEcCtD
Dantrolene—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000399	0.00118	CcSEcCtD
Dantrolene—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000398	0.00118	CcSEcCtD
Dantrolene—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000398	0.00118	CcSEcCtD
Dantrolene—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000398	0.00118	CcSEcCtD
Dantrolene—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000397	0.00117	CcSEcCtD
Dantrolene—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000396	0.00117	CcSEcCtD
Dantrolene—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000396	0.00117	CcSEcCtD
Dantrolene—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000396	0.00117	CcSEcCtD
Dantrolene—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.00117	CcSEcCtD
Dantrolene—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000395	0.00117	CcSEcCtD
Dantrolene—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000395	0.00117	CcSEcCtD
Dantrolene—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000393	0.00116	CcSEcCtD
Dantrolene—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000393	0.00116	CcSEcCtD
Dantrolene—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000392	0.00116	CcSEcCtD
Dantrolene—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000391	0.00116	CcSEcCtD
Dantrolene—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000389	0.00115	CcSEcCtD
Dantrolene—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000388	0.00115	CcSEcCtD
Dantrolene—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000387	0.00114	CcSEcCtD
Dantrolene—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000384	0.00114	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000384	0.00114	CcSEcCtD
Dantrolene—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000383	0.00113	CcSEcCtD
Dantrolene—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000383	0.00113	CcSEcCtD
Dantrolene—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000383	0.00113	CcSEcCtD
Dantrolene—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000382	0.00113	CcSEcCtD
Dantrolene—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000382	0.00113	CcSEcCtD
Dantrolene—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000381	0.00113	CcSEcCtD
Dantrolene—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000381	0.00113	CcSEcCtD
Dantrolene—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000381	0.00113	CcSEcCtD
Dantrolene—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00038	0.00112	CcSEcCtD
Dantrolene—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00038	0.00112	CcSEcCtD
Dantrolene—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00038	0.00112	CcSEcCtD
Dantrolene—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000378	0.00112	CcSEcCtD
Dantrolene—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000377	0.00112	CcSEcCtD
Dantrolene—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000377	0.00111	CcSEcCtD
Dantrolene—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000377	0.00111	CcSEcCtD
Dantrolene—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000377	0.00111	CcSEcCtD
Dantrolene—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000376	0.00111	CcSEcCtD
Dantrolene—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000376	0.00111	CcSEcCtD
Dantrolene—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000375	0.00111	CcSEcCtD
Dantrolene—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000374	0.00111	CcSEcCtD
Dantrolene—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000373	0.0011	CcSEcCtD
Dantrolene—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000372	0.0011	CcSEcCtD
Dantrolene—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000371	0.0011	CcSEcCtD
Dantrolene—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000371	0.0011	CcSEcCtD
Dantrolene—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000369	0.00109	CcSEcCtD
Dantrolene—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000369	0.00109	CcSEcCtD
Dantrolene—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000369	0.00109	CcSEcCtD
Dantrolene—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000368	0.00109	CcSEcCtD
Dantrolene—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000367	0.00109	CcSEcCtD
Dantrolene—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000367	0.00109	CcSEcCtD
Dantrolene—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000367	0.00108	CcSEcCtD
Dantrolene—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000365	0.00108	CcSEcCtD
Dantrolene—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000365	0.00108	CcSEcCtD
Dantrolene—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000365	0.00108	CcSEcCtD
Dantrolene—Rash—Stavudine—acquired immunodeficiency syndrome	0.000364	0.00108	CcSEcCtD
Dantrolene—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000364	0.00108	CcSEcCtD
Dantrolene—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000363	0.00108	CcSEcCtD
Dantrolene—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000363	0.00107	CcSEcCtD
Dantrolene—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000363	0.00107	CcSEcCtD
Dantrolene—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000363	0.00107	CcSEcCtD
Dantrolene—Headache—Stavudine—acquired immunodeficiency syndrome	0.000361	0.00107	CcSEcCtD
Dantrolene—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000361	0.00107	CcSEcCtD
Dantrolene—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.00107	CcSEcCtD
Dantrolene—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000361	0.00107	CcSEcCtD
Dantrolene—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000361	0.00107	CcSEcCtD
Dantrolene—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00036	0.00107	CcSEcCtD
Dantrolene—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00036	0.00106	CcSEcCtD
Dantrolene—Rash—Abacavir—acquired immunodeficiency syndrome	0.000358	0.00106	CcSEcCtD
Dantrolene—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000358	0.00106	CcSEcCtD
Dantrolene—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000358	0.00106	CcSEcCtD
Dantrolene—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000358	0.00106	CcSEcCtD
Dantrolene—Headache—Abacavir—acquired immunodeficiency syndrome	0.000356	0.00105	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000355	0.00105	CcSEcCtD
Dantrolene—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000355	0.00105	CcSEcCtD
Dantrolene—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000355	0.00105	CcSEcCtD
Dantrolene—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000353	0.00104	CcSEcCtD
Dantrolene—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000351	0.00104	CcSEcCtD
Dantrolene—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00035	0.00104	CcSEcCtD
Dantrolene—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000348	0.00103	CcSEcCtD
Dantrolene—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000348	0.00103	CcSEcCtD
Dantrolene—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000347	0.00103	CcSEcCtD
Dantrolene—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000347	0.00103	CcSEcCtD
Dantrolene—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000346	0.00102	CcSEcCtD
Dantrolene—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000345	0.00102	CcSEcCtD
Dantrolene—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000344	0.00102	CcSEcCtD
Dantrolene—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000344	0.00102	CcSEcCtD
Dantrolene—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000343	0.00102	CcSEcCtD
Dantrolene—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000343	0.00102	CcSEcCtD
Dantrolene—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000343	0.00101	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000342	0.00101	CcSEcCtD
Dantrolene—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.00101	CcSEcCtD
Dantrolene—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000339	0.001	CcSEcCtD
Dantrolene—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.001	CcSEcCtD
Dantrolene—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000338	0.000999	CcSEcCtD
Dantrolene—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000336	0.000994	CcSEcCtD
Dantrolene—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000335	0.000991	CcSEcCtD
Dantrolene—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000335	0.00099	CcSEcCtD
Dantrolene—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000334	0.000987	CcSEcCtD
Dantrolene—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.000986	CcSEcCtD
Dantrolene—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.000986	CcSEcCtD
Dantrolene—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000333	0.000986	CcSEcCtD
Dantrolene—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000333	0.000986	CcSEcCtD
Dantrolene—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000332	0.000981	CcSEcCtD
Dantrolene—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00033	0.000977	CcSEcCtD
Dantrolene—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00033	0.000976	CcSEcCtD
Dantrolene—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.000965	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000326	0.000965	CcSEcCtD
Dantrolene—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000325	0.00096	CcSEcCtD
Dantrolene—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000324	0.000958	CcSEcCtD
Dantrolene—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000324	0.000957	CcSEcCtD
Dantrolene—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000321	0.00095	CcSEcCtD
Dantrolene—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000321	0.000949	CcSEcCtD
Dantrolene—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000321	0.000949	CcSEcCtD
Dantrolene—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000319	0.000944	CcSEcCtD
Dantrolene—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000319	0.000943	CcSEcCtD
Dantrolene—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000319	0.000943	CcSEcCtD
Dantrolene—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000318	0.000942	CcSEcCtD
Dantrolene—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000316	0.000935	CcSEcCtD
Dantrolene—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000316	0.000935	CcSEcCtD
Dantrolene—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000316	0.000935	CcSEcCtD
Dantrolene—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000315	0.000932	CcSEcCtD
Dantrolene—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000314	0.000929	CcSEcCtD
Dantrolene—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000312	0.000922	CcSEcCtD
Dantrolene—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.000921	CcSEcCtD
Dantrolene—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000311	0.000919	CcSEcCtD
Dantrolene—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00031	0.000916	CcSEcCtD
Dantrolene—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.000915	CcSEcCtD
Dantrolene—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000309	0.000913	CcSEcCtD
Dantrolene—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000308	0.000912	CcSEcCtD
Dantrolene—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.000912	CcSEcCtD
Dantrolene—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.000912	CcSEcCtD
Dantrolene—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000307	0.000908	CcSEcCtD
Dantrolene—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.000906	CcSEcCtD
Dantrolene—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.000906	CcSEcCtD
Dantrolene—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000303	0.000895	CcSEcCtD
Dantrolene—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000302	0.000892	CcSEcCtD
Dantrolene—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000298	0.000882	CcSEcCtD
Dantrolene—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000298	0.000882	CcSEcCtD
Dantrolene—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000298	0.000881	CcSEcCtD
Dantrolene—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000297	0.000878	CcSEcCtD
Dantrolene—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000297	0.000878	CcSEcCtD
Dantrolene—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000297	0.000877	CcSEcCtD
Dantrolene—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.000873	CcSEcCtD
Dantrolene—Rash—Indinavir—acquired immunodeficiency syndrome	0.000294	0.00087	CcSEcCtD
Dantrolene—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000294	0.000869	CcSEcCtD
Dantrolene—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000293	0.000866	CcSEcCtD
Dantrolene—Headache—Indinavir—acquired immunodeficiency syndrome	0.000292	0.000864	CcSEcCtD
Dantrolene—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000291	0.000862	CcSEcCtD
Dantrolene—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000288	0.000853	CcSEcCtD
Dantrolene—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00085	CcSEcCtD
Dantrolene—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000284	0.000841	CcSEcCtD
Dantrolene—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.000837	CcSEcCtD
Dantrolene—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.000837	CcSEcCtD
Dantrolene—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.000829	CcSEcCtD
Dantrolene—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.000828	CcSEcCtD
Dantrolene—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.000825	CcSEcCtD
Dantrolene—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000278	0.000822	CcSEcCtD
Dantrolene—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000278	0.000821	CcSEcCtD
Dantrolene—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00082	CcSEcCtD
Dantrolene—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.000818	CcSEcCtD
Dantrolene—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000276	0.000817	CcSEcCtD
Dantrolene—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000276	0.000816	CcSEcCtD
Dantrolene—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.000797	CcSEcCtD
Dantrolene—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000268	0.000793	CcSEcCtD
Dantrolene—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.000789	CcSEcCtD
Dantrolene—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.000786	CcSEcCtD
Dantrolene—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.000786	CcSEcCtD
Dantrolene—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000266	0.000785	CcSEcCtD
Dantrolene—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000264	0.000781	CcSEcCtD
Dantrolene—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.00078	CcSEcCtD
Dantrolene—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.000774	CcSEcCtD
Dantrolene—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.000763	CcSEcCtD
Dantrolene—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00076	CcSEcCtD
Dantrolene—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.00076	CcSEcCtD
Dantrolene—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.000749	CcSEcCtD
Dantrolene—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.000741	CcSEcCtD
Dantrolene—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.000734	CcSEcCtD
Dantrolene—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.000733	CcSEcCtD
Dantrolene—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.000727	CcSEcCtD
Dantrolene—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.000727	CcSEcCtD
Dantrolene—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.000725	CcSEcCtD
Dantrolene—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.000723	CcSEcCtD
Dantrolene—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.000706	CcSEcCtD
Dantrolene—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.0007	CcSEcCtD
Dantrolene—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.0007	CcSEcCtD
Dantrolene—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.000699	CcSEcCtD
Dantrolene—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.000695	CcSEcCtD
Dantrolene—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000685	CcSEcCtD
Dantrolene—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.000673	CcSEcCtD
Dantrolene—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.000668	CcSEcCtD
Dantrolene—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.000667	CcSEcCtD
Dantrolene—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000224	0.000663	CcSEcCtD
Dantrolene—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.000659	CcSEcCtD
Dantrolene—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000629	CcSEcCtD
